The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000801314
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
27/05/2026
Date registered
Help: Date registered
3/07/2026
Date last updated
Help: Date last updated
3/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
3/07/2026
Date results provided
Help: Date results provided
3/07/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Island Study Linking Ageing and Neurodegenerative Disease: Investigating the impact of a public health approach to dementia prevention
Scientific title
Island Study Linking Ageing and Neurodegenerative Disease: Investigating the impact of a public health approach to dementia prevention in community Tasmanian members.
Additional trial identifiers [1] 317778 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
dementia 342074 0
Condition category
Condition code
Neurological 338185 338185 0 0
Dementias
Public Health 338352 338352 0 0
Health service research

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
We are tracking adherence to modifiable risk factors for dementia over time, including lifestyle risk factors such as smoking, education and physical activity. We measure these via surveys completed each year via a dedicated online portal known as 'ISLAND Home', and track participant engagement in educational content regarding risk factor reduction. Participants complete a series of validated questionnaires annually to assess dementia knowledge, risk awareness, health behaviours, and psychosocial wellbeing. The Dementia Risk Knowledge survey (KoDERR) takes approximately 5 minutes to complete and assesses understanding of modifiable dementia risk factors. The Dementia Knowledge Assessment Scale (DKAS) takes around 10 minutes and measures broader knowledge about dementia. Motivation to engage in dementia risk reduction behaviours is assessed using the Motivation to Change Lifestyle and Health Behaviours for Dementia Risk Reduction scale (MCLHB-DRR), which takes approximately 10–15 minutes. The Dementia Risk Profile (DRP), which evaluates engagement in dementia risk and protective behaviours, takes around 15–20 minutes to complete. Symptoms of depression and anxiety are assessed using the Hospital Anxiety and Depression Scale (HADS), requiring approximately 5 minutes. Social connectedness and support are measured using the Lubben Social Network Scale (LSNS), which takes approximately 5 minutes to complete. A custom survey designed for ISLAND asks about background health and lifestyle factors, taking approximately 5-10 minutes. In total, the annual survey battery takes approximately 50–60 minutes to complete. Overall duration of observation is from enrolment until the completion of the study in 2029. Retrospective data was collected from 2019 to current.
Intervention code [1] 334205 0
Not applicable
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345558 0
Dementia Risk
Timepoint [1] 345558 0
Baseline and 10 years, annual assessments every year
Secondary outcome [1] 462159 0
Cognition
Timepoint [1] 462159 0
Cognition is measured every two years (2021, 2023, 2025, 2027, 2029). Participants who enrol post 1/10/2027 will have cognition assessed in 2029.

Eligibility
Key inclusion criteria
Being a Tasmanian resident
Being 50 years of age or older
Minimum age
50 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
N/A

Study design
Purpose
Screening
Duration
Longitudinal
Selection
Defined population
Timing
Retrospective
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
TAS

Funding & Sponsors
Funding source category [1] 321932 0
Government body
Name [1] 321932 0
National Health and Medical Research Council
Country [1] 321932 0
Australia
Funding source category [2] 321982 0
Charities/Societies/Foundations
Name [2] 321982 0
Hopkin's Foundation
Country [2] 321982 0
Australia
Funding source category [3] 321983 0
Charities/Societies/Foundations
Name [3] 321983 0
J.O. and J.R. Wicking Trust (Equity Trustees)
Country [3] 321983 0
Australia
Funding source category [4] 321984 0
Commercial sector/Industry
Name [4] 321984 0
St. Luke’s Health
Country [4] 321984 0
Australia
Funding source category [5] 321985 0
Charities/Societies/Foundations
Name [5] 321985 0
Masonic Centenary Medical Research Foundation
Country [5] 321985 0
Australia
Primary sponsor type
University
Name
University of Tasmania
Address
Country
Australia
Secondary sponsor category [1] 324859 0
None
Name [1] 324859 0
Address [1] 324859 0
Country [1] 324859 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320467 0
University of Tasmania Human Research Ethics Committee
Ethics committee address [1] 320467 0
Ethics committee country [1] 320467 0
Australia
Date submitted for ethics approval [1] 320467 0
01/07/2019
Approval date [1] 320467 0
01/08/2019
Ethics approval number [1] 320467 0
H40267

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150566 0
Dr Eddy Roccati
Address 150566 0
Office 421c, Medical Sciences Precinct, University of Tasmania, 17 Liverpool St, Hobart, 7000, Tasmania
Country 150566 0
Australia
Phone 150566 0
+61 03 6226 4228
Fax 150566 0
Email 150566 0
Contact person for public queries
Name 150567 0
Eddy Roccati
Address 150567 0
Office 421c, Medical Sciences Precinct, University of Tasmania, 17 Liverpool St, Hobart, 7000, Tasmania
Country 150567 0
Australia
Phone 150567 0
+61 03 6226 4228
Fax 150567 0
Email 150567 0
Contact person for scientific queries
Name 150568 0
Eddy Roccati
Address 150568 0
Office 421c, Medical Sciences Precinct, University of Tasmania, 17 Liverpool St, Hobart, 7000, Tasmania
Country 150568 0
Australia
Phone 150568 0
+61 03 6226 4228
Fax 150568 0
Email 150568 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: There is no consent for data sharing of individual participant data at present.



What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Study protocolBartlett, L., Doherty, K., Farrow, M., Kim, S., Hill, E., King, A., Alty, J., Eccleston, C., Kitsos, A., Bindoff, A. and Vickers, J.C., 2022. Island study linking aging and neurodegenerative disease (ISLAND) targeting dementia risk reduction: protocol for a prospective web-based cohort study. JMIR research protocols, 11(3), p.e34688.https://pubmed.ncbi.nlm.nih.gov/35230251/[email protected] 2022_ISLAND_Protocol.pdf


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Interim results articleYeshttps://doi.org/10.1186/s12889-023-16805-2 Bartlett, L., Bindoff, A., Doherty, K., Kim, S., E... [More Details] 2023_ISLAND_Interim_Results.pdf

Documents added automatically
No additional documents have been identified.